Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonists are effective glucose-lowering agents with established benefits on body weight and cardiometabolic outcomes.
- The effects of glucagon-like peptide-1 receptor agonists on body composition are not fully understood.
- Dietary intake patterns, including food group consumption, may be influenced by these agents.
- The impact on macronutrient energy distribution in clinical settings remains unclear.
Simplified